PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25807318 ↗2015Reported benefit

Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid.

MouseRadiationC57BL/6FemaleSubcutaneous (earlier work used oral and intraperitoneal)Therapeutic doses around 1 mg/kg; 10 mg/kg given without ob…From 24 h before to 72 h after irradiation

Model: Total-body irradiation (lethal dose; 6.4 to 8.6 Gy range used for dose modification factor analysis)

A single dose given between 12 h before and 26 h after lethal total-body irradiation reduced mortality by 50%, and dosing at 48 to 72 h after irradiation reduced mortality by at least 34%; dose modification factor was 1.2 using LD50/10.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.